Methods of delivery of cetyl myristoleate
CA 2371064 A1 · Owner: Cg And Associates · Inventors: Lytle, Carol D.; Lord, Gary R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides novel and advantageous delivery devices for compositions of cetyl myristoleate. The delivery devices include transdermal delivery devices, suppositories, intranasal delivery devices enteric , coatings, and micro-encapsulation. Further provided are methods of treating pain and diseases using the disclosed delivery devices. Diseases that can be treated with the devices include, but are not limited to diseases associated , with the pain or inflammation of tissues diseases associated with pain or , inflammatory conditions affecting joints autoimmune diseases, and allergies.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 28, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 28, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 28, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.